• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

    69.08 -1.42 (-2.01%)
    Streaming Delayed Price Updated: 2:35 PM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 318,564
    Open 70.49
    Bid (Size) 68.98 (100)
    Ask (Size) 69.16 (100)
    Prev. Close 70.50
    Today's Range 68.62 - 71.38
    52wk Range 35.95 - 87.50
    Shares Outstanding 81,474,366
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PTC Therapeutics Inc (NASDAQ:PTCT) Stock Slides After Q4 Earnings Miss ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill

    Performance

    YTD
    -10.0%
    -10.0%
    1 Month
    -9.4%
    -9.4%
    3 Month
    -13.5%
    -13.5%
    6 Month
    +40.1%
    +40.1%
    1 Year
    +38.1%
    +38.1%

    More News

    Read More
    PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Moderate Valuation ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Combines High-Growth Momentum with Bullish Technical Setup ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Emerges as a High-Growth Momentum Breakout Candidate ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT) Combines Strong Growth with a Bullish Technical Setup ↗
    Via Chartmill
    PTC Therapeutics Inc (NASDAQ:PTCT): A Prime Candidate for Affordable Growth Investing ↗
    Via Chartmill
    News headline image
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Shows High-Growth Momentum and Bullish Technical Setup ↗
    Via Chartmill
    Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You? ↗
    Via The Motley Fool
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    PTC Therapeutics Inc (NASDAQ:PTCT) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill
    News headline image
    PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Reasonable Valuation ↗
    Via Chartmill
    News headline image
    Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    Via MarketMinute
    News headline image
    Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? ↗
    Via The Motley Fool
    News headline image
    A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000 ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents an Affordable Growth Opportunity ↗
    Via Chartmill
    News headline image
    This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally ↗
    Via The Motley Fool
    News headline image
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Shows Strong Growth Momentum and Technical Health ↗
    Via Chartmill
    News headline image
    Sarepta Therapeutics Shares Plummet as Key DMD Treatments Miss Primary Endpoint in Late-Stage Trial
    Via MarketMinute
    Topics Death
    News headline image
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents a Compelling Mix of Strong Growth and Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    PTC THERAPEUTICS INC (NASDAQ:PTCT) Presents an Affordable Growth Opportunity ↗
    Via Chartmill

    Frequently Asked Questions

    Is PTC Therapeutics, Inc. - Common Stock publicly traded?
    Yes, PTC Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does PTC Therapeutics, Inc. - Common Stock trade on?
    PTC Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for PTC Therapeutics, Inc. - Common Stock?
    The ticker symbol for PTC Therapeutics, Inc. - Common Stock is PTCT on the Nasdaq Stock Market
    What is the current price of PTC Therapeutics, Inc. - Common Stock?
    The current price of PTC Therapeutics, Inc. - Common Stock is 69.08
    When was PTC Therapeutics, Inc. - Common Stock last traded?
    The last trade of PTC Therapeutics, Inc. - Common Stock was at 02/24/26 02:35 PM ET
    What is the market capitalization of PTC Therapeutics, Inc. - Common Stock?
    The market capitalization of PTC Therapeutics, Inc. - Common Stock is 5.63B
    How many shares of PTC Therapeutics, Inc. - Common Stock are outstanding?
    PTC Therapeutics, Inc. - Common Stock has 6B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.